# Shanghai INT Medical Instruments to acquire 51.7% stake in Endonom Medical

Shanghai INT Medical Instruments Co., Ltd. will acquire a 51.7% stake in Endonom Medical (Hangzhou) for RMB 324 million (USD 45 million), as part of a joint acquisition of 81.83% with Shanghai Chenyue Weixin Medical Technology Co., Ltd.

- Type: Acquisition
- Announced: 2025-05-22
- Where: China
- Value: $45.0M (324.0M CNY)
- Status: announced
- Products: intracardiac interventional devices, peripheral vascular intervention medical devices
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Shanghai INT Medical Instruments Co., Ltd.](https://endata.com/companies/84916.md) (acquirer)
- [Endonom Medical (Hangzhou)](https://endata.com/companies/84917.md) (target)
- [Shanghai Chenyue Weixin Medical Technology Co., Ltd.](https://endata.com/companies/84918.md) (partner)

## Sources

- [flcube.com](https://flcube.com/shanghai-int-medical-instruments-to-acquire-majority-stake-in-endonom-medical/), 2025-05-22: "INT Med will obtain a 51.7% stake in Endonom Med for RMB 324 million (USD 45 million)."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.